aids vaccines - CISMeF

Preferred Label : aids vaccines;

MeSH definition : Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.;

MeSH synonym : AIDS Vaccine; Vaccine, AIDS;

Wikipedia automatic translation : HIV/AIDS;

Related MeSH term : HIV vaccines; HIV Vaccine; Vaccine, HIV;

Wikipedia link : https://en.wikipedia.org/wiki/HIV/AIDS;

Is substance : O;

Details

Origin ID

D016915;

UMLS CUI

C0085432;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- HIV Vaccine [NCIt concept]
Indexing information
- NAKTIIVQL nanopeptide [MeSH Supplementary Concept]
- PPD-MN-PND vaccine [MeSH Supplementary Concept]
- TBI protein, recombinant [MeSH Supplementary Concept]
Record concept(s)
- AIDS vaccines [MeSH concept]
- HIV vaccines [MeSH concept]
Related MeSH Supplementary Concept(s)
- AIDSVAX [MeSH Supplementary Concept]
- AIDSVAX B-E [MeSH Supplementary Concept]
- ALVAC-HIV vCP1452 [MeSH Supplementary Concept]
- ALVAC-HIV vCP205 vaccine [MeSH Supplementary Concept]
- ALVAC-HIV vCP300 [MeSH Supplementary Concept]
- ALVAC-HIV-1 vCP205 [MeSH Supplementary Concept]
- ALVAC-HIV-1 vCP250 [MeSH Supplementary Concept]
- DNA-rAd5 vaccine [MeSH Supplementary Concept]
- DermaVir [MeSH Supplementary Concept]
- HIV peplotion vaccine [MeSH Supplementary Concept]
- HIV type 1 lipopeptide vaccine [MeSH Supplementary Concept]
- HIV-1 IIIB gp120 subunit vaccine [MeSH Supplementary Concept]
- HIV-1 immunogen, incomplete freund's adjuvant [MeSH Supplementary Concept]
- HIV-1 recombinant subtype CRF02 AG DNA vaccine [MeSH Supplementary Concept]
- HIV-LIPO-6T [MeSH Supplementary Concept]
- HIVAC-1e [MeSH Supplementary Concept]
- MNrgp120 vaccine [MeSH Supplementary Concept]
- MVA-HIV-1 nef vaccine [MeSH Supplementary Concept]
- MVA-HIVA vaccine [MeSH Supplementary Concept]
- NYVAC-C vaccine [MeSH Supplementary Concept]
- V-1 immunitor [MeSH Supplementary Concept]
- Vacc-4x [MeSH Supplementary Concept]
- VaxSyn HIV-1 (gp160) vaccine [MeSH Supplementary Concept]
- human immunodeficiency virus type 1 tat vaccine [MeSH Supplementary Concept]
- p24-VLP vaccine [MeSH Supplementary Concept]
- pTHr.HIVA [MeSH Supplementary Concept]
- remune [MeSH Supplementary Concept]
- retanef [MeSH Supplementary Concept]
- salk HIV immunogen [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- acquired immunodeficiency syndrome [MeSH Descriptor]
- hiv infections [MeSH Descriptor]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients